跳至主要内容
临床试验/EUCTR2005-001510-40-ES
EUCTR2005-001510-40-ES进行中(未招募)不适用

Prospective randomized study to assess the efficacy and tolerability of ferrimannitol ovoalbumin compared to ferrous sulphate in the treatment of iron deficiency anaemia

TEDEC MEIJI FARMA, S.A.0 个研究点开始时间: 2006年5月16日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients > 18 years old
  • Diagnosis of iron deficiency anaemia
  • Informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Anaemia not related with iron deficiency
  • Pregnancy and lactation
  • Diseases with iron overload
  • Patients who have received iron treatment within the previous 3 months prior to the inclusion in the study.
  • Digestive pathology that may cause intolerance or malabsortion
  • Hepatic insufficiency
  • Chronic pancreatitis
  • Renal insufficiency
  • AIDS or seropositive patients, infection, neoplasia or continuos haemorrhage

研究者

发起方
TEDEC MEIJI FARMA, S.A.

相似试验